BACKGROUND - Findings from epidemiologic studies examining associations of serum retinol and carotenoids with prostate cancer risk have been inconsistent. This case-control study nested in the Prostate Cancer Prevention Trial evaluated associations of serum retinol and carotenoids with total, low- and high-grade prostate cancer risk in a highly-screened study population.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
METHODS - We used logistic regression adjusting for age, family history of prostate cancer, race, BMI and serum cholesterol to estimate odds ratios (OR) and 95% confidence intervals (CI) of prostate cancer by quartiles of serum retinol and carotenoids, separately in the placebo (975 cases/1009 frequency-matched controls) and finasteride (708 cases/743 frequency-matched controls) arms of the trial.
RESULTS - Serum retinol concentrations were associated with increased risk of total prostate cancer [OR (95% CI) comparing the highest quartile of serum retinol to the lowest: 1.30 (1.00, 1.68)] and high-grade prostate cancer [OR (95% CI): 1.74 (1.14, 2.68)] in the placebo arm of the trial only. Also in the placebo arm, there was a moderate positive association of α-carotene with risk of total prostate cancer [OR (95% CI): 1.32 (1.01, 1.73)]. None of the other carotenoids was associated with prostate cancer risk in the placebo arm. No associations were observed for retinol and carotenoids in the finasteride arm.
CONCLUSIONS - In the placebo arm of this prospective study, high serum retinol and α-carotene concentrations were associated with increased risk of total and high-grade prostate cancers.
IMPACT - Men with higher levels of serum retinol and α-carotene may be at increased risk for prostate cancer.
Cancer Epidemiol Biomarkers Prev. 2015 Aug 12. pii: cebp.0394.2015. [Epub ahead of print]
Nash SH1, Till C2, Song X3, Lucia MS4, Parnes HL5, Thompson IM Jr6, Lippman SM7, Platz EA8, Schenk J9.
1 Cancer Prevention Fellowship Program, National Cancer Institute.
2 Fred Hutchinson Cancer Research Center.
3 Cancer Prevention Program, Fred Hutchinson Cancer Research Center.
4 Pathology, University of Colorado.
5 DCP, NCI.
6 Cancer Therapy and Research Center, The University of Texas Health Science Center at San Antonio.
7 University of California, San Diego, Moores Cancer Center.
8 Epidemiology, Johns Hopkins University School of Public Health.
9 Fred Hutchinson Cancer Research Center